Evaluation of the NaviFUS System in Drug Resistant Epilepsy

Abroad (travel likely)Recruiting

Conditions

Epilepsy, Temporal Lobe · Drug Resistant Epilepsy

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The Alfred, Melbourne, Victoria, Australia
Contact: Study coordinator (Caitlin Roberts, Ms.) · cai.roberts@alfred.org.au · +61 3 9076 2598
Contact: Principal Investigator (Terence O'Brien, Prof.)

Study leads

Terrence O'Brien, Prof.
Principal Investigator
The Alfred

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Safety, Tolerability, and Preliminary Efficacy of Low-intensity Focused Ultrasound Neuromodulation in Patients With Drug-resistant Epilepsy

Drug Resistant Epilepsy · Epilepsy · Seizures, Focal

Abroad (travel likely)RecruitingPHASE1, PHASE2

Palo Alto, United States · Boston, United States

Surgery as a Treatment for Medically Intractable Epilepsy

Epilepsy · Epilepsy, Temporal Lobe · Partial Epilepsy

Abroad (travel likely)Recruiting

Bethesda, United States

Investigating Epilepsy: Screening and Evaluation

Seizures · Epilepsy · Epilepsy, Temporal Lobe

Abroad (travel likely)Recruiting

Bethesda, United States

Exploratory Study of UX-GIP001 Cell Therapy in Adult Patients With Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (MTLE)

Epilepsy · MTLE

Abroad (travel likely)RecruitingEARLY_PHASE1

Hangzhou, China